BioPharm International-09-01-2016

BioPharm International

Efforts Accelerate to Streamline Postapproval Change Process

September 01, 2016

Regulatory Beat

29

9

Manufacturers and regulatory authorities seek coordinated lifecycle management policies.

Innovation vs. Capacity: How CMOs Compete

September 01, 2016

Perspectives on Outsourcing

29

9

The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.

BioPharm International, September 2016 Issue (PDF)

September 01, 2016

Issue PDF

29

9

Click the title above to open the BioPharm International September 2016 issue in an interactive PDF format.

PDA Issues Call to Action for Faster Postapproval Changes

August 29, 2016

Regulatory Beat

29

9

The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.

When Marketing and Medicine Collide

August 24, 2016

From the Editor

29

9

Steep price increases for a popular drug have created patient and Congressional backlash.